{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:08:07Z","timestamp":1780632487627,"version":"3.54.1"},"reference-count":51,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[1993,7]]},"abstract":"<jats:p>The present reference drugs for the treatment of panic disorder and agoraphobia are imipramine and alprazolam. The latter decreases performance and cognitive functioning. No study of such functions in panic\/agoraphobia is available. Fifty four out-patients meeting DSM-III-R criteria for panic disorder with or without agoraphobia (PAG), taking part in a parallel groups controlled trial of imipramine (mean dose \u00b1SEM 114\u00b19 mg), clomipramine (50\u00b14 mg) and propanteline (active placebo) over 8 weeks, were studied. A test battery of psychomotor and memory tests was administered at baseline, and after 1, 4 and 8 weeks of treatment. Their results were compared (at baseline and at the end of the trial) with those of a control group of 57 normal untreated subjects. There was no difference between treatments, and no drug effect on any test at any time. No consistent difference between patients and controls was detected. Given its apparently higher potency, and the absence of deleterious effects on cognitive measures known to be affected by benzodiazepines, we conclude that clomipramine is better than imipramine or alprazolam as a reference drug for panic\/agoraphobia.<\/jats:p>","DOI":"10.1177\/026988119300700403","type":"journal-article","created":{"date-parts":[[2007,3,17]],"date-time":"2007-03-17T23:45:17Z","timestamp":1174175117000},"page":"325-330","source":"Crossref","is-referenced-by-count":9,"title":["Clomipramine, a better reference drug for panic\/agoraphobia. II. Psychomotor and cognitive effects"],"prefix":"10.1177","volume":"7","author":[{"given":"T.","family":"Marcourakis","sequence":"first","affiliation":[{"name":"Centro de Investiga\u00e7\u00f5es em Neurologia, Faculdade de Medicina USP, Departamento de Farmacologia, Instituto de Ci\u00eancias Biom\u00e9dicas USP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gorenstein","sequence":"additional","affiliation":[{"name":"Departamento de Farmacologia, Instituto de Ci\u00eancias Biom\u00e9dicas USP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gentil","sequence":"additional","affiliation":[{"name":"Departamento de Psiquiatria, LIM-23, Faculdade de Medicina, Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[1993,7,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265843"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb03097.x"},{"key":"atypb3","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatry Association","year":"1987","edition":"3"},{"key":"atypb4","first-page":"57","volume":"16","author":"Amin M.M.","year":"1980","journal-title":"Psychopharmacol Bull"},{"key":"atypb5","volume-title":"Depression. Clinical, experimental and theoretical aspects","author":"Beck AT","year":"1967"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245787"},{"key":"atypb7","volume-title":"Manual para o invent\u00e1rio de ansiedade tra\u00e7o-estado (IDATE)","author":"Biaggio A M B","year":"1979"},{"key":"atypb8","first-page":"17","volume":"25","author":"Bond A.J.","year":"1972","journal-title":"Psychopharmacologia"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700045803"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700011077"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(88)90054-7"},{"key":"atypb12","first-page":"24","volume":"38","author":"Correa D.D.","year":"1988","journal-title":"Arq Bras Psicol"},{"key":"atypb13","first-page":"42","volume":"40","author":"Correa D.D.","year":"1988","journal-title":"Arq Bras Psicol"},{"key":"atypb14","first-page":"105","volume":"10","author":"Deptula D.","year":"1990","journal-title":"J Clin Psychiatr"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00733.x"},{"key":"atypb16","first-page":"316","volume":"7","author":"Gentil V.","year":"1993","journal-title":"Effectiveness comparison with imipramine. J Psychopharmacol"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198906000-00006"},{"key":"atypb18","first-page":"10","volume":"14","author":"Glass R.M.","year":"1978","journal-title":"Psychopharmacol Bull"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.9.1215"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198902000-00006"},{"key":"atypb21","first-page":"941","volume":"23","author":"Gorenstein C.","year":"1990","journal-title":"Methodological considerations. Braz J Med Biol Res"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.9.966"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb05503.x"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00732.x"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1007\/BF00310629"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198701000-00003"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.119.5.432"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00444684"},{"key":"atypb29","first-page":"51","volume":"126","author":"Kornetsky C.","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094319"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00430494"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00440847"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(85)90034-X"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(85)90104-4"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199208000-00007"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(91)90038-T"},{"key":"atypb37","first-page":"649","volume":"19","author":"Raskin A.","year":"1983","journal-title":"Psychopharmacol Bull"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975175515"},{"key":"atypb39","first-page":"214","volume":"10","author":"Seppala T.","year":"1978","journal-title":"Ann Clin Res"},{"key":"atypb40","volume-title":"Drug treatment in psychiatry","author":"Silverstone T.","year":"1974"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.2307\/2527917"},{"key":"atypb42","volume-title":"Manual for the State-Trait anxiety inventory","author":"Spielberger C.D.","year":"1970"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770020055009"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470060202"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170005563X"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1945.9917223"},{"key":"atypb47","volume-title":"Manual for the Wechsler adult intelligence scale","author":"Wechsler D.A.","year":"1955"},{"key":"atypb48","first-page":"27","volume":"18","author":"Weingartner H.","year":"1982","journal-title":"Psychopharmacol Bull"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196208000-00006"},{"key":"atypb50","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426327"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140065007"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119300700403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119300700403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:39Z","timestamp":1777507899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026988119300700403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["10.1177\/026988119300700403"],"URL":"https:\/\/doi.org\/10.1177\/026988119300700403","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}